Table 1 Demographics by tumour type.
From: Early treatment-related neutropenia predicts response to palbociclib
Cancer type | Breast | Other |
|---|---|---|
Total patients | 61 | 135 |
Age in years, median (range) | 58 (34–88) | 55 (17–87) |
Sex, N (%)a | ||
Female | 61 (100) | 48 (36) |
Male | 0 (0) | 87 (64) |
Race, N (%) | ||
White | 56 (92) | 113 (84) |
Black | 3 (5) | 9 (7) |
Asian/other | 2 (3) | 13 (10) |
BMI, median (range)b | 25 (19–47) | 26 (16–48) |
Baseline ECOG PS, N (%) | ||
0 | 40 (66) | 82 (61) |
1 | 21 (34) | 53 (39) |
# Prior lines of therapy, N (%)a | ||
0 | 0 (0) | 24 (18) |
1 | 3 (5) | 49 (36) |
2 | 4 (7) | 23 (17) |
≥3 | 54 (88) | 39 (29) |
Immediate prior line chemotherapy, N (%) | ||
Yes | 35 (57) | 86 (64) |
No | 26 (43) | 49 (36) |
Baseline ANC (K/μL), median (range) | 4.0 (1.6–10.4) | 4.4 (1.5–31.9) |
